New attack on superbug in CF lungs
NCT ID NCT03489629
Summary
This study tested a two-week antibiotic treatment to clear a dangerous bacteria called MRSA from the lungs of people with cystic fibrosis. Thirty-seven participants aged 2 to 45 received oral antibiotics, a nasal ointment, and mouthwash. Researchers checked if the treatment successfully cleared the infection and if it reduced lung flare-ups over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cook Children's Medical Center
Fort Worth, Texas, 76104, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
N.C. Memorial Hospital and N.C. Children's Hospital
Chapel Hill, North Carolina, 27599, United States
-
National Jewish Health
Denver, Colorado, 80206, United States
-
St. Louis Children's Hospital
St Louis, Missouri, 63110, United States
-
Texas Children's Hospital, Baylor College of Medicine
Houston, Texas, 77030, United States
-
University of Michigan Health System
Ann Arbor, Michigan, 48109, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Washington Medical Center and Seattle Children's
Seattle, Washington, 98195, United States
Conditions
Explore the condition pages connected to this study.